Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Aschaffenburg
Clinical trial register · Germany

Clinical Trials in Aschaffenburg, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca5 University of Ulm3 Hoffmann-La Roche2 Acerta Pharma BV2 Goethe University2
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Aschaffenburg

47 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Recruiting
Novartis Pharmaceuticals
Observational
380
Baden-Baden, Heidenheim, Schwäbisch Hall, Winnenden, Aschaffenburg, Augsburg, Donauwörth, Herrsching am Ammersee
2026-04-17
Recruiting
Ipsen
Observational
150
Aschaffenburg, Berlin, Bonn, Bremen, Chemnitz, Cologne, Dresden, Erlangen
2025-12-17
Recruiting
Janssen Research & Development, LLC
Observational
380
Aschaffenburg, Bielefeld, Bochum, Chemnitz, Cologne, Düsseldorf, Essen, Hamburg
2025-12-03
Recruiting
Relay Therapeutics, Inc.
Phase 3
540
Aschaffenburg, Bottrop, Dresden, Eggenfelden, Erlangen, Freiburg im Breisgau, Krefeld, Mannheim
2025-08-26
Active, closed
Upstream Bio Inc.
Phase 2
666
Aschaffenburg, Augsburg, Bamberg, München, Cottbus, Hamburg, Darmstadt, Frankfurt am Main
2025-07-02
Recruiting
MedSIR
Phase 2
200
Aschaffenburg, Augsburg, Dresden, Essen, Worms
2025-06-30
Recruiting
Sanofi
Observational
150
Aschaffenburg, Augsburg, Dachau, Erlangen, Giessen, Wetzlar, Osnabrück, Weyhe-Kirchweyhe
2025-05-28
Recruiting
Fruquintinib in Patients With Metastatic Colorectal Cancer
NCT06787105Metastatic Colorectal Cancer (mCRC)
iOMEDICO AG
Observational
150
Biberach, Freiburg im Breisgau, Heidelberg, Ravensburg, Schorndorf, Weinheim, Aschaffenburg, Fürth
2025-02-17
Recruiting
Elacestrant + Everolimus in Patients ER+/HER2-, ESR1mut, Advanced Breast Cancer Progressing to ET and CDK4/6i.
NCT06382948Advanced Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, ESR1 Gene Mutation
DrugsElacestrant·Everolimus
MedSIR
Phase 3
300
Aschaffenburg, Augsburg, Dessau, Düsseldorf, Essen, Georgsmarienhütte, Worms
2024-12-05
Recruiting
Hoffmann-La Roche
Observational
842
Aachen, Amberg, Arnsdorf, Aschaffenburg, Bad Soden, Bamberg, Berg, Berlin
2024-09-26
Active, closed
Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)
NCT06430866Early-stage Non-squamous Non-small Cell Lung Cancer (NSCLC)
DrugsABP 234·Pembrolizumab
Amgen
Phase 3
163
Aschaffenburg, Essen
2024-09-12
Recruiting
AstraZeneca
Observational
300
Ahrensburg, Ansbach, Aschaffenburg, Auerbach, Augsburg, Bad Homburg, Berlin, Cottbus
2024-07-25
Recruiting
Fresenius Medical Care Deutschland GmbH
Not applicable
46
Aschaffenburg, Munich, Braunschweig, Paderborn, Berlin, Ulm, Würzburg
2024-07-18
Active, closed
Analysis of TPE Treatments With multiFiltratePRO
NCT06272084Autoimmune Diseases
Fresenius Medical Care Deutschland GmbH
Observational
60
Aschaffenburg, Würzburg, Berlin
2024-05-22
Active, closed
AstraZeneca
Observational
111
Aschaffenburg, Augsburg, Bergisch Gladbach, Berlin, Bonn, Cologne, Dresden, Duisburg
2024-02-14
Active, closed
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Observational
257
Aschaffenburg, Berlin, Cologne, Essen, Göppingen, Hamburg, Hanover, München
2023-12-05
Recruiting
AstraZeneca
Observational
800
Amberg, Ansbach, Apolda, Aschaffenburg, Augsburg, Bad Reichenhall, Baden-Baden, Balingen
2023-09-12
Recruiting
Goethe University
Phase 2
220
Aachen, Aschaffenburg, Augsburg, Bad Saarow, Bayreuth, Berlin, Bielefeld, Bochum
2023-07-14
Active, closed
Swedish Orphan Biovitrum
Observational
165
Goettigen, Aschaffenburg, Frankfurt am Main, Giessen, Offenbach, Essen, Leipzig, Saalfeld
2023-06-26
Recruiting
Universität des Saarlandes
Phase 3
330
Homburg, Aschaffenburg, Berlin, Dresden, Giessen, Greifswald, Halle, Karlsruhe
2023-06-07
Recruiting
Acandis GmbH
Observational
153
Aschaffenburg, Augsburg, Bonn, Bremerhaven, Dresden, Duisburg, Erfurt, Halle
2023-01-25
Recruiting
Institut fuer Frauengesundheit
Phase 4
1,000
Erlangen, Mainz, Bottrop, Amberg, Aschaffenburg, Augsburg, Bamberg, Berlin
2022-10-12
Recruiting
University of Ulm
Phase 3
650
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2022-09-13
Active, closed
AstraZeneca
Phase 3
644
Aschaffenburg, Bonn, Frankfurt am Main, Georgsmarienhütte, Hanover, Heilbronn, Koblenz Am Rhein, Langen
2022-05-16
Recruiting
Prof. Wolfgang Janni
Phase 4
300
Aalen, Amberg, Aschaffenburg, Augsburg, Berlin, Biberach, Bonn, Braunschweig
2022-04-27
Recruiting
ITP Registry and Accompanying Biospecimen Collection
NCT05152238Immune Thrombocytopenia
Jena University Hospital
Observational
1,100
Aachen, Altenburg, Aschaffenburg, Bad Homburg, Bad Liebenwerda, Berlin, Biberach, Bochum
2021-11-29
Active, closed
AstraZeneca
Observational
752
Böblingen, Göttingen, Nürtingen, Osnabrück, Rotenburg (Wümme), Aachen, Amberg, Aschaffenburg
2021-06-15
Active, closed
ExThera Medical Corporation
Not applicable
42
Aschaffenburg, Berlin, Essen
2021-05-04
Active, closed
Hoffmann-La Roche
Phase 2
303
Aschaffenburg, Berlin, Hamburg, Paderborn, Stralsund
2020-11-27
Recruiting
Pierre Fabre Pharma GmbH
Observational
500
Offenburg, Ulm, Augsburg, Donauwörth, Erlangen, München, Würzburg, Aschaffenburg
2020-09-03
Recruiting
University of Erlangen-Nürnberg Medical School
Observational
5,000
Aschaffenburg, Bad Aibling, Bad Neustadt an der Saale, Bayreuth, Coburg, Freyung, München, Neumarkt
2020-08-10
Active, closed
University of Leipzig
Not applicable
5,227
München, Nuremberg, Bremen, Leipzig, Berlin, Altenburg, Aschaffenburg, Augsburg
2020-07-07
Active, closed
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
777
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-12-20
Recruiting
Pierre Fabre Pharma GmbH
Observational
750
Ahaus, Aschaffenburg, Augsburg, Berlin, Bremerhaven, Buxtehude, Chemnitz, Donauwörth
2019-10-17
Active, closed
University of Ulm
Phase 3
882
Aschaffenburg, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig, Bremen, Darmstadt
2019-09-04
Active, closed
Ipsen
Observational
224
Aachen, Aschaffenburg, Augsburg, Bad Homburg, Bad Liebenwerda, Bad Schlema, Bamberg, Bergisch Gladbach
2018-09-24
Recruiting
AbbVie
Observational
500
Mutlangen, Stuttgart, Villingen-Schwenningen, Aschaffenburg, Augsburg, Bad Reichenhall, Erlangen, Hof
2017-12-04
Active, closed
Acerta Pharma BV
Phase 3
310
Aschaffenburg, Dresden, Mutlangen, München, Ulm
2017-02-02
Active, closed
Geron Corporation
Phase 2/3
289
Freiburg im Breisgau, Dresden, Leipzig, Aschaffenburg, Bonn, Düsseldorf, Mainz
2016-01-12
Active, closed
RWTH Aachen University
Phase 2
207
Mannheim, Ulm, Winnenden, Aschaffenburg, Müchen, Nuremberg, Hamburg, Mainz
2015-10
Active, closed
Acerta Pharma BV
Phase 3
535
Aschaffenburg, Bielefeld, Erlangen, Heilbronn, Warzburg
2015-06-26
Active, closed
Bristol-Myers Squibb
Observational
2,555
Heidelberg, Hamm, Aschaffenburg, Berlin, Dresden, Magdeburg, München, Rostock
2012-06-13
Active, closed
Apotransferrin in Atransferrinemia
NCT01797055Congenital Atransferrinemia
Prothya Biosolutions
Phase 2
5
Aschaffenburg
2010-12
Recruiting
University of Ulm
Observational
50,000
Aschaffenburg, Augsburg, Aurich, Bad Saarow, Berlin, Bochum, Bonn, Braunschweig
2010-07-06
Recruiting
Goethe University
Observational
10,000
Frankfurt am Main, Aachen, Altenburg, Altötting, Aschaffenburg, Augsburg, Bad Saarow, Bamberg
2009-02
Active, closed
Genentech, Inc.
Phase 2
378
Aschaffenburg, Berlin, München
2008-10-16
Recruiting
University of Giessen
Phase 2/3
210
Ansbach, Aschaffenburg, Bad Neustadt an der Saale, Berlin, Bremen, Celle, Cottbus, Darmstadt
2004-05
Rows per page Showing 1–47 of 47
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/aschaffenburg

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 47 of those studies with a site in Aschaffenburg.

How many clinical trials are recruiting in Aschaffenburg?

26 of the 47 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 21 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Aschaffenburg), 47 studies
PhaseStudiesRecruitingShare
Observational231648.9%
Phase 310421.3%
Phase 27214.9%
Not applicable316.4%
Phase 2/3214.3%
Phase 4224.3%

Most active sponsors

Lead sponsors with the most studies (Aschaffenburg)
Lead sponsorStudiesRecruiting
AstraZeneca52
University of Ulm32
Acerta Pharma BV20
Fresenius Medical Care Deutschland GmbH21
Goethe University22
Hoffmann-La Roche21
Ipsen21
MedSIR22
Pierre Fabre Pharma GmbH22
AbbVie11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.